Shin-Etsu Polymer (7970) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
14 Jul, 2026Corporate philosophy and strengths
Pursues value creation through technology and products, aiming for sustainable growth and social contribution.
Operates as a global resin processing manufacturer, leveraging group synergies from material development to processing.
Maintains a strong technological base in silicone and various resins, offering high value-added products across diverse industries.
Business strategy and growth initiatives
Implements a mid-term management plan targeting 2029, focusing on business, financial, and non-financial strategies.
Prioritizes rapid execution of strategies to achieve set goals, especially in growth markets like semiconductors, next-gen automobiles, and medical fields.
Advances sustainability initiatives to address social challenges and contribute to a sustainable society.
Technology and R&D
Core technologies include material formulation, design, processing, and evaluation, with a focus on silicone, resins, and conductive materials.
Expands core technologies to strengthen existing products and develop next-generation solutions.
Emphasizes early value creation through deepening foundational technologies and evolving core competencies.
Latest events from Shin-Etsu Polymer
- Profits and sales rose on robust AI-related semiconductor and automotive demand, but FY2027 outlook is uncertain.7970
Q4 202622 May 2026 - Precision molding and advanced materials drive global growth, led by innovation and sustainability.7970
Corporate presentation20 Mar 2026 - Operating profit rose 5.7% despite lower sales, with full-year guidance and dividends increased.7970
Q1 202520 Mar 2026 - Operating profit rose 17.7% on strong Precision Molding and semiconductor market recovery.7970
Q2 202520 Mar 2026 - Strong profit growth and robust segment performance support an optimistic full-year outlook.7970
Q3 202520 Mar 2026 - Operating profit rose 20.1% year-over-year, led by semiconductors; FY2026 outlook withheld.7970
Q4 202520 Mar 2026 - Strong profit growth and higher dividend forecast, led by semiconductor and medical demand.7970
Q1 202620 Mar 2026 - Profits rose on semiconductor strength, but comprehensive income fell on currency losses.7970
Q2 202620 Mar 2026 - Year-over-year profit growth driven by strong core segments, despite FX headwinds.7970
Q3 202620 Mar 2026